Nature: FDA Approval of New Drugs and Sales Forecast in 2021
On January 4, Nature magazine made an inventory of new drugs approved by the US FDA in 2021, and made sales forecasts. In addition, statistics have been made on new drugs that will be approved in 2022.
Although the impact of COVID-19 continues, the number of FDA approvals last year is consistent with the trend in recent years. The FDA's Center for Drug Evaluation and Research (CDER) approved 50 new therapies in 2021, down from 53 in 2020. In the past five years, CDER has approved an average of 51 new drugs each year. Ten years ago, there were 24 models per year.
The number of new drugs approved by the FDA since 1993
According to the Clarivate Analytics database, analysts expect only 8 new drugs approved by CDER to have the potential to become blockbusters. In 2027, Biogen's aducanumab is the only drug that is expected to exceed the $2 billion mark. Given the disadvantages faced by this controversial Alzheimer's drug, this is also a speculative bet.
You May Interested In
Glow70/KLOW80 99% China Peptides Warehouse Direct Delivery Lyophilized Powder in Stock
$169/UNIT FOB
2026-10-18
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA takes key action in fight against COVID-19 by issuing Emergency Use Authoriz
-
Pakistan Launches Successive Anti-dumping Investigations against Chinese Products, Involving Soda Ash, Ibuprofen and Other Raw Materials
-
Colombia Makes Preliminary Ruling in Anti-Dumping Investigation into Chinese DOP Imports
-
U.S. Finds Chinese Potassium Phosphate Dumping Could Recur at Margins Up to 95.40%
-
U.S. Finds Methionine Dumping Could Recur, With Japan Margin Up to 76.50%
-
U.S. Finds Methionine Dumping Could Recur, With Japan Margin Up to 76.50%
-
EU PIC Amendment Adds Over 30 Chemicals to Control List and Bans 3 POPs Exports
-
FDA Lifts Administrative Stay, Restoring Red No. 3 Ban Timeline for Food and Ingested Drugs
-
India’s Tariff Cuts Could Lower Agrochemical Costs
-
FDA Tightens the Solvent Side of Natural Color Production
Recommend Reading
-
![FSANZ Moves Toward Approval of Insect-Resistant Corn COR121]()
FSANZ Moves Toward Approval of Insect-Resistant Corn COR121
-
![Thymol Gel Wins EPA Approval for Beekeepers]()
Thymol Gel Wins EPA Approval for Beekeepers
-
![U.S. Sets Preliminary 107.57% Countervailing Rate on Chinese Rubber Accelerator CBS]()
U.S. Sets Preliminary 107.57% Countervailing Rate on Chinese Rubber Accelerator CBS
-
![UK Proposes Anti-Dumping Duties of Up to 63.66% on Chinese Rutile Titanium Dioxide]()
UK Proposes Anti-Dumping Duties of Up to 63.66% on Chinese Rutile Titanium Dioxide
-
![FDA Slows Two Natural Color Approvals, but the Additive Shift Is Still Moving]()
FDA Slows Two Natural Color Approvals, but the Additive Shift Is Still Moving
-
![Raw Materials Strong, Demand Weak—ABS Prices Rise in July and Then Stabilize]()
Raw Materials Strong, Demand Weak—ABS Prices Rise in July and Then Stabilize
-
![Business Society October 13, 2026 PVC Trend Analysis: Market Bias Toward the Bearish Side]()
Business Society October 13, 2026 PVC Trend Analysis: Market Bias Toward the Bearish Side
-
![Business Society October 13, 2026 Acrylonitrile Trend Analysis: Uptrend Confirmed]()
Business Society October 13, 2026 Acrylonitrile Trend Analysis: Uptrend Confirmed
-
![Cost Values and Demand-Side Game: PP Prices Consolidate After Rising in July]()
Cost Values and Demand-Side Game: PP Prices Consolidate After Rising in July
-
![Business Society October 13, 2026 LLDPE Trend Analysis: Strong Consolidation]()
Business Society October 13, 2026 LLDPE Trend Analysis: Strong Consolidation
